van der Schoot CE - Search Results

1

Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia.

Verhagen OJ, Willemse MJ, Breunis WB, Wijkhuijs AJ, Jacobs DC, Joosten SA, van Wering ER, van Dongen JJ, van der Schoot CE. Verhagen OJ, et al. Among authors: van dongen jj, van der schoot ce, van wering er. Leukemia. 2000 Aug;14(8):1426-35. doi: 10.1038/sj.leu.2401801. Leukemia. 2000. PMID: 10942239

2

Quality assessment of immunological marker analysis and the immunological diagnosis in leukaemia and lymphoma: a multi-centre study. Dutch Cooperative Study Group on Immunophenotyping of Leukaemias and Lymphomas (SIHON).

van't Veer MB, Kluin-Nelemans JC, van der Schoot CE, van Putten WL, Adriaansen HJ, van Wering ER. van't Veer MB, et al. Among authors: van putten wl, van der schoot ce, van wering er. Br J Haematol. 1992 Apr;80(4):458-65. doi: 10.1111/j.1365-2141.1992.tb04558.x. Br J Haematol. 1992. PMID: 1581230

3

Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia.

Steenbergen EJ, Verhagen OJ, van Leeuwen EF, van den Berg H, Behrendt H, Slater RM, von dem Borne AE, van der Schoot CE. Steenbergen EJ, et al. Among authors: van den berg h, van der schoot ce, van leeuwen ef. Leukemia. 1995 Oct;9(10):1726-34. Leukemia. 1995. PMID: 7564517

4

Frequent ongoing T-cell receptor rearrangements in childhood B-precursor acute lymphoblastic leukemia: implications for monitoring minimal residual disease.

Steenbergen EJ, Verhagen OJ, van Leeuwen EF, van den Berg H, von dem Borne AE, van der Schoot CE. Steenbergen EJ, et al. Among authors: van den berg h, van der schoot ce, van leeuwen ef. Blood. 1995 Jul 15;86(2):692-702. Blood. 1995. PMID: 7606000 Free article.

5

IgH/TCR delta PCR oligonucleotide liquid hybridization, a fast and sensitive assay for monitoring minimal residual disease in childhood B-precursor ALL.

Steenbergen EJ, Verhagen OJ, van Leeuwen EF, van den Berg H, Behrendt H, von dem Borne AE, van der Schoot CE. Steenbergen EJ, et al. Among authors: van den berg h, van der schoot ce, van leeuwen ef. Leukemia. 1995 Jan;9(1):216-22. Leukemia. 1995. PMID: 7845021

6

Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression.

Adriaansen HJ, te Boekhorst PA, Hagemeijer AM, van der Schoot CE, Delwel HR, van Dongen JJ. Adriaansen HJ, et al. Among authors: van dongen jj, van der schoot ce. Blood. 1993 Jun 1;81(11):3043-51. Blood. 1993. PMID: 8098967 Free article.

7

B precursor acute lymphoblastic leukemia third complementarity-determining regions predominantly represent an unbiased recombination repertoire: leukemic transformation frequently occurs in fetal life.

Steenbergen EJ, Verhagen OJ, van Leeuwen EF, Behrendt H, Merle PA, Wester MR, von dem Borne AE, van der Schoot CE. Steenbergen EJ, et al. Among authors: van der schoot ce, van leeuwen ef. Eur J Immunol. 1994 Apr;24(4):900-8. doi: 10.1002/eji.1830240418. Eur J Immunol. 1994. PMID: 8149961

8

Distinct ongoing Ig heavy chain rearrangement processes in childhood B-precursor acute lymphoblastic leukemia.

Steenbergen EJ, Verhagen OJ, van Leeuwen EF, von dem Borne AE, van der Schoot CE. Steenbergen EJ, et al. Among authors: van der schoot ce, van leeuwen ef. Blood. 1993 Jul 15;82(2):581-9. Blood. 1993. PMID: 8329713 Free article.

9

[Children with acute lymphoblastic leukemia: prognostic significance of polymerase-chain-reaction analysis of minimal residual disease].

Steenbergen EJ, Verhagen OJ, van den Berg H, van Leeuwen EF, von dem Borne AE, van der Schoot CE. Steenbergen EJ, et al. Among authors: van den berg h, van der schoot ce, van leeuwen ef. Ned Tijdschr Geneeskd. 1996 Jan 6;140(1):22-8. Ned Tijdschr Geneeskd. 1996. PMID: 8569906 Dutch.

10

Clonal evolution of immunoglobulin heavy chain rearrangements in childhood B-precursor acute lymphoblastic leukemia after engraftment in SCID mice.

Steenbergen EJ, Verhagen OJ, Nibbering CP, van den Berg H, van Leeuwen EF, Behrendt H, von dem Borne AE, van der Schoot CE. Steenbergen EJ, et al. Among authors: van den berg h, van der schoot ce, van leeuwen ef. Leukemia. 1996 Sep;10(9):1471-8. Leukemia. 1996. PMID: 8751465

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

354 results

Search Page